Blood test for ctDNA identifies patients who benefit from celecoxib after surgery

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their blood after surgery to remove the cancer, may benefit from adding of celecoxib, to post surgery treatment.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests

Amid controversy and discussions about the high cost of cancer drugs, some academic medical centers profit handsomely from pharma-paid royalties on drugs developed with public

April 20, 2024

Two reproductive health conditions associated with increasing cardiovascular disease risk in women

Two reproductive health conditions common in women, polycystic ovary syndrome and dysmenorrhea, are each associated with increasing cardiovascular disease risk, according to two preliminary studies

November 6, 2023

New study reveals molecular mechanism in Alzheimer’s disease

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.